
Modulating the gut microbiome could represent a new frontier for cancer medicine
In early 2022, the MD Anderson Cancer Center in Houston began enrolling patients with late-stage disease for a unique clinical trial. With a matter of months to live, and all other treatment options exhausted, the centre’s oncologists offered these …